Search research articles
Contact Us
Filters
Showing results (161-170 of 194) with videos related to
Page
of 20
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
June 15, 2019
Plasma AR status and cabazitaxel in heavily treated metastatic castration-resistant prostate cancer
Vincenza Conteduca, Elena Castro, Daniel Wetterskog, et al.
JAMA Oncology
|
July 25, 2024
BRCA1, BRCA2, and Associated Cancer Risks and Management for Male Patients: A Review
Heather H Cheng, Jeffrey W Shevach, Elena Castro, et al.
Translational Psychiatry
|
November 20, 2019
Dopaminergic control of ADAMTS2 expression through cAMP/CREB and ERK: molecular effects of antipsychotics
Fulgencio Ruso-Julve, Ana Pombero, Fuencisla Pilar-Cuéllar, et al.
British Journal of Cancer
|
August 23, 2018
Phase II pilot study of the prednisone to dexamethasone switch in metastatic castration-resistant prostate cancer (mCRPC) patients with limited progression on abiraterone plus prednisone (SWITCH study)
Nuria Romero-Laorden, Rebeca Lozano, Anuradha Jayaram, et al.
BJU International
|
January 17, 2013
Clinical implications of family history of prostate cancer and genetic risk single nucleotide polymorphism (SNP) profiles in an active surveillance cohort
Chee L Goh, Edward J Saunders, Daniel A Leongamornlert, et al.
European Urology
|
December 3, 2014
Effect of BRCA Mutations on Metastatic Relapse and Cause-specific Survival After Radical Treatment for Localised Prostate Cancer
Elena Castro, Chee Goh, Daniel Leongamornlert, et al.
European Urology Oncology
|
July 17, 2019
Early Post-treatment Prostate-specific Antigen at 4 Weeks and Abiraterone and Enzalutamide Treatment for Advanced Prostate Cancer: An International Collaborative Analysis
Pasquale Rescigno, David Dolling, Vincenza Conteduca, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 24, 2021
Association between BRCA2 alterations and intraductal and cribriform histologies in prostate cancer
Rebeca Lozano, Daniela C Salles, Shahneen Sandhu, et al.
Science Advances
|
October 2, 2024
SRSF6 modulates histone-chaperone HIRA splicing to orchestrate AR and E2F activity in prostate cancer
Antonio J Montero-Hidalgo, Juan M Jiménez-Vacas, Enrique Gómez-Gómez, et al.
European Urology
|
February 19, 2019
Plasma Androgen Receptor and Docetaxel for Metastatic Castration-resistant Prostate Cancer
Vincenza Conteduca, Anuradha Jayaram, Nuria Romero-Laorden, et al.
Page
of 20
Search research articles
Search
Showing results (161-170 of 194) with videos related to
Sort By:
Page
of 20
European Journal of Cancer (Oxford, England : 1990)
|
June 15, 2019
Plasma AR status and cabazitaxel in heavily treated metastatic castration-resistant prostate cancer
Vincenza Conteduca, Elena Castro, Daniel Wetterskog, et al.
JAMA Oncology
|
July 25, 2024
BRCA1, BRCA2, and Associated Cancer Risks and Management for Male Patients: A Review
Heather H Cheng, Jeffrey W Shevach, Elena Castro, et al.
Translational Psychiatry
|
November 20, 2019
Dopaminergic control of ADAMTS2 expression through cAMP/CREB and ERK: molecular effects of antipsychotics
Fulgencio Ruso-Julve, Ana Pombero, Fuencisla Pilar-Cuéllar, et al.
British Journal of Cancer
|
August 23, 2018
Phase II pilot study of the prednisone to dexamethasone switch in metastatic castration-resistant prostate cancer (mCRPC) patients with limited progression on abiraterone plus prednisone (SWITCH study)
Nuria Romero-Laorden, Rebeca Lozano, Anuradha Jayaram, et al.
BJU International
|
January 17, 2013
Clinical implications of family history of prostate cancer and genetic risk single nucleotide polymorphism (SNP) profiles in an active surveillance cohort
Chee L Goh, Edward J Saunders, Daniel A Leongamornlert, et al.
European Urology
|
December 3, 2014
Effect of BRCA Mutations on Metastatic Relapse and Cause-specific Survival After Radical Treatment for Localised Prostate Cancer
Elena Castro, Chee Goh, Daniel Leongamornlert, et al.
European Urology Oncology
|
July 17, 2019
Early Post-treatment Prostate-specific Antigen at 4 Weeks and Abiraterone and Enzalutamide Treatment for Advanced Prostate Cancer: An International Collaborative Analysis
Pasquale Rescigno, David Dolling, Vincenza Conteduca, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 24, 2021
Association between BRCA2 alterations and intraductal and cribriform histologies in prostate cancer
Rebeca Lozano, Daniela C Salles, Shahneen Sandhu, et al.
Science Advances
|
October 2, 2024
SRSF6 modulates histone-chaperone HIRA splicing to orchestrate AR and E2F activity in prostate cancer
Antonio J Montero-Hidalgo, Juan M Jiménez-Vacas, Enrique Gómez-Gómez, et al.
European Urology
|
February 19, 2019
Plasma Androgen Receptor and Docetaxel for Metastatic Castration-resistant Prostate Cancer
Vincenza Conteduca, Anuradha Jayaram, Nuria Romero-Laorden, et al.
Page
of 20